Effects of transcatheter arterial chemoembolization in combination with portal vein chemotherapy on survival of patients after resection of hepatocellular carcinoma

VernacularTitle:肝动脉插管化疗栓塞联合门静脉化疗对肝细胞癌病人术后生存期的影响
Author: Jianbin ZHUANG ; Yijun WANG ; Zhi DU ; Fuhua NIE ; Guiming SHU ; Jun WANG ; Chengjun LU ; Qiang YUAN
Publication Type:Journal Article
Keywords: Carcinoma,hepatocellular; TACE/PVC; Survival
From: Chinese Journal of Hepatobiliary Surgery 2010;16(8):579-581
CountryChina
Language:Chinese
Abstract: Objective To study the value of transcatheter arterial chemoembolization (TACE)in combination with portal vein chemotherapy (PVC) after resection of hepatocellular carcinoma to prolong survival. Methods From January 2000 to July 2007, 168 patients with hepatocellular carcinoma (HCC) underwent tumor resection in our hospital. After operation, TACE in combination with PVC was performed in 48 patients (combined group), TACE alone in 26 (TACE group), PVC alone in 50 (PVC group) and none of the above in 44 (control group). All the patients were followed up for 17-96 months. The 1-, 3-and 5-year survival rates were compared among the 4 groups. Results Accumulative 1-, 3-and 5-year survival rates were higher in the combined and TACE groups than in PVC and control groups. Conclusion After resection of HCC, combined use of TACE and PVC is the same as TACE in prolonging patient survival. However, it is better than PVC alone and non-surgical procedure.